Viatris Total Liabilities 2010-2024 | VTRS

Viatris total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Viatris total liabilities for the quarter ending September 30, 2024 were $24.962B, a 10.46% decline year-over-year.
  • Viatris total liabilities for 2023 were $27.218B, a 5.98% decline from 2022.
  • Viatris total liabilities for 2022 were $28.95B, a 15.72% decline from 2021.
  • Viatris total liabilities for 2021 were $34.35B, a 11.01% decline from 2020.
Viatris Annual Total Liabilities
(Millions of US $)
2023 $27,218
2022 $28,950
2021 $34,350
2020 $38,599
2019 $19,372
2018 $20,568
2017 $22,499
2016 $23,609
2015 $12,502
2014 $12,545
2013 $12,335
2012 $8,576
2011 $8,093
2010 $7,921
2009 $7,657
Viatris Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $24,962
2024-06-30 $25,810
2024-03-31 $27,329
2023-12-31 $27,218
2023-09-30 $27,877
2023-06-30 $27,852
2023-03-31 $28,362
2022-12-31 $28,950
2022-09-30 $29,480
2022-06-30 $31,320
2022-03-31 $33,019
2021-12-31 $34,350
2021-09-30 $34,929
2021-06-30 $36,777
2021-03-31 $37,565
2020-12-31 $38,599
2020-09-30 $18,695
2020-06-30 $18,409
2020-03-31 $18,883
2019-12-31 $19,372
2019-09-30 $19,590
2019-06-30 $19,914
2019-03-31 $20,015
2018-12-31 $20,568
2018-09-30 $21,389
2018-06-30 $21,063
2018-03-31 $22,008
2017-12-31 $22,499
2017-09-30 $22,527
2017-06-30 $22,673
2017-03-31 $22,617
2016-12-31 $23,609
2016-09-30 $24,710
2016-06-30 $18,505
2016-03-31 $12,369
2015-12-31 $12,502
2015-09-30 $11,502
2015-06-30 $13,225
2015-03-31 $13,031
2014-12-31 $12,545
2014-09-30 $11,768
2014-06-30 $12,250
2014-03-31 $12,163
2013-12-31 $12,335
2013-09-30 $9,669
2013-06-30 $9,266
2013-03-31 $8,998
2012-12-31 $8,576
2012-09-30 $8,082
2012-06-30 $8,403
2012-03-31 $8,155
2011-12-31 $8,093
2011-09-30 $7,624
2011-06-30 $8,125
2011-03-31 $7,961
2010-12-31 $7,921
2010-09-30 $7,864
2010-06-30 $7,619
2010-03-31 $7,644
2009-12-31 $7,657
2009-09-30 $7,691
2009-06-30 $7,330
2009-03-31 $7,247
Sector Industry Market Cap Revenue
Medical Medical Services $14.478B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.995B 10.55
Cencora (COR) United States $43.734B 16.44
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $20.871B 0.00
ICON (ICLR) Ireland $16.879B 15.03
Avantor (AVTR) United States $14.307B 21.45
Revvity (RVTY) United States $13.453B 23.37
BioMerieux (BMXMF) France $12.659B 0.00
CochLear (CHEOY) Australia $11.807B 0.00
Solventum (SOLV) United States $11.540B 0.00
Medpace Holdings (MEDP) United States $10.417B 29.35
Doximity (DOCS) United States $10.302B 60.64
Charles River Laboratories (CRL) United States $9.314B 18.00
HealthEquity (HQY) United States $8.212B 41.20
Sonic Healthcare (SKHHY) Australia $8.208B 0.00
Bausch + Lomb (BLCO) Canada $6.322B 29.43
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.759B 20.11
Organon (OGN) United States $3.719B 3.75
BrightSpring Health Services (BTSG) United States $2.967B 63.11
Surgery Partners (SGRY) United States $2.493B 28.42
Concentras Parent (CON) United States $2.491B 0.00
Ardent Health Partners (ARDT) United States $2.291B 0.00
GeneDx Holdings (WGS) United States $2.069B 0.00
Premier (PINC) United States $2.067B 10.76
PACS (PACS) United States $1.992B 0.00
Alignment Healthcare (ALHC) United States $1.969B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.730B 0.00
GoodRx Holdings (GDRX) United States $1.711B 44.90
Teladoc Health (TDOC) United States $1.544B 0.00
Pediatrix Medical (MD) United States $1.224B 11.98
Progyny (PGNY) United States $1.208B 24.47
Embecta (EMBC) United States $1.161B 8.12
CareDx (CDNA) United States $1.102B 0.00
Establishment Labs Holdings (ESTA) $1.090B 0.00
AMN Healthcare Services Inc (AMN) United States $0.874B 5.91
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.775B 0.00
SBC Medicals (SBC) United States $0.649B 0.00
Auna S.A (AUNA) Luxembourg $0.492B 0.00
InnovAge Holding (INNV) United States $0.478B 0.00
DocGo (DCGO) United States $0.444B 16.73
Sonida Senior Living (SNDA) United States $0.441B 0.00
Enhabit (EHAB) United States $0.387B 33.48
Sera Prognostics (SERA) United States $0.275B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.268B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Biodesix (BDSX) United States $0.198B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
ModivCare (MODV) United States $0.156B 8.44
MultiPlan (MPLN) United States $0.108B 0.00
Ascend Wellness Holdings (AAWH) United States $0.099B 0.00
So-Young (SY) China $0.093B 15.69
IceCure Medical (ICCM) Israel $0.052B 0.00
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeueHealth (NEUE) United States $0.033B 0.87
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Cano Health (CANOQ) United States $0.001B 0.00
Aclarion (ACON) United States $0.001B 0.00